이상반응 보고

VAERS ID	2247534
성별	여성
나이	72세
주 코드	FR
제약회사	MODERNA
로트 번호
예방접종 횟수	2
접종일	2021-11-04
발병일	2021-11-11
상태	입원

증상

• 근육 약화(Muscular weakness)

이환 중 질병

지병

기타 의료

이전 예방접종

알레르기

임상 검사

증상 상세

Limb weakness; This regulatory authority case was reported by an other health care professional and describes the occurrence of MUSCULAR WEAKNESS (Limb weakness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.
No Medical History information was reported.
On 04-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.
On 11-Nov-2021, the patient experienced MUSCULAR WEAKNESS (Limb weakness) (seriousness criterion hospitalization).
The patient was hospitalized on 30-Mar-2022 due to MUSCULAR WEAKNESS.
At the time of the report, MUSCULAR WEAKNESS (Limb weakness) was resolving.
For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
No concomitants and treatment medications were reported.
On 11-Nov-2021, patient experienced left hand weakness.
On 30-Mar-2022, the patient was hospitalized.
Company Comment: This regulatory authority case concerns 72 years female patient with no medical history, who experienced unexpected serious (seriousness criterion hospitalization) event of muscular weakness, which occurred 7 days after second dose of mRNA-1273 vaccine.
The benefit-risk relationship of mRNA-1273 is not affected by this report.
The event was assessed as serious as per Regulatory Authority´s report.
Sender's Comments: This regulatory authority case concerns 72 years female patient with no medical history, who experienced unexpected serious (seriousness criterion hospitalization) event of muscular weakness, which occurred 7 days after second dose of mRNA-1273 vaccine.
The benefit-risk relationship of mRNA-1273 is not affected by this report.
The event was assessed as serious as per Regulatory Authority´s report.